Lynx MD raises $12 million Seed funding for AI healthcare data platform
The Israeli startup’s sandboxed environment allows users to access massive amounts of real-world medical data and facilitates decisions using data science and AI
Lynx MD, which has developed a healthcare AI platform for real world clinical and operational data collaboration, announced on Monday that it has raised $12 million in Seed financing. The round was led by MizMaa Ventures with participation from New York Life Ventures, Amdocs, and iAngels, as well as existing investors Triventures, UpWest and notable angels.
Lynx MD team. Photo: Lynx
Real world data is critical to drive innovation and improve care in the healthcare industry, but security hurdles, patient privacy concerns and IT resource shortages make it difficult for clinical leaders, researchers, and analysts to access patient data at scale. Lynx aims to solve these challenges with its sandboxed environment which allows users to access massive amounts of real-world medical data and facilitates decisions using data science and AI.
- U.S. pharma giant West to invest in Israeli incubator MEDX Xelerator
- Israel’s Alike.Health selected for Google's first European acceleration program for medical startups
- Navina secures $15 million Series A for AI primary care platform
“AI and machine learning models are only as good as the data which feeds them. Quality, variety and volume of the data are key,” said Omer Dror, co-founder and CEO of Lynx. “This is especially true and important in the healthcare industry where people’s lives are at stake. AI has incredible potential to help researchers, drug developers, and doctors discover new ways to improve patient outcomes and the healthcare industry overall, but only if we solve the data access conundrum.”